Approval · Notice of Compliance 16938 · 2015
NORLEVO: Notice of Compliance 16938
Issued May 28, 2015
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 16938
- Date
- May 28, 2015
- Company
- Laboratoire Hra PharmaChâtillon, France
- Product type
- Nonprescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Switch from prescription to non-prescription status for new 1.5 mg tablet
- Therapeutic class
- Emergency contraception
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| NORLEVO | 02322919 | Approved |
Medicinal ingredients
- LEVONORGESTREL 1.5 MG per TAB